Vol 36, No 2 (February 2015): Acta Pharmacologica Sinica

Review

Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers   Pages (149–157) Open
Jian SHI
The use of marine-derived bioactive compounds as potential hepatoprotective agents   Pages (158–170)
Dileep G NAIR, Ralf WEISKIRCHEN, Salma K Al-MUSHARAFI

Original Article

The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma   Pages (171–178)
Jing XU, Yan-ting ZHU, Gui-zuo WANG, Dong HAN, Yuan-yuan WU, De-xin ZHANG, Yun LIU, Yong-hong ZHANG, Xin-ming XIE, Shao-jun LI, Jia-mei LU, Lu LIU, Wei FENG, Xiu-zhen SUN, Man-xiang LI
Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice   Pages (179–187)
Min XU, Fa-le CAO, Yu-fei ZHANG, Liang SHAN, Xiao-ling JIANG, Xiao-jing AN, Wei XU, Xiu-zhi LIU, Xiao-yan WANG
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy   Pages (188–199)
Tian-tian LI, Xiao-hui ZHANG, Jing-feng JING, Xin LI, Xiao-qian YANG, Feng-hua ZHU, Wei TANG, Jian-ping ZUO
Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients   Pages (200–208)
Ping FENG, De-min YU, Li-ming CHEN, Bao-cheng CHANG, Qiu-di JI, Shu-ying LI, Mei ZHU, Sheng-hua DING, Baozhen ZHANG, Su-li WANG, Hong-tao LI, Jing-na LIN, Mao-jun WANG, Jian-chao GUO, Jie LIU, Zhong-dong LIU, Shentao WU, Ju-hong YANG, Clinical Cooperation Group of Liraglutid in Chinese Type 2 Diabetes
Antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model   Pages (209–220)
Hatem M Abuohashish, Mohammed M Ahmed, Salim S Al-Rejaie, Kamal EH ELTahir
Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling   Pages (221–228)
Lei ZHEN, De-sheng FAN, Yan ZHANG, Xin-ming CAO, Li-ming WANG
Sanguinarine inhibits Rac1b-rendered cell survival enhancement by promoting apoptosis and blocking proliferation   Pages (229–240)
Li YING, Gang LI, Si-si WEI, Hong WANG, Pei AN, Xun WANG, Kai GUO, Xian-jin LUO, Ji-min GAO, Qing ZHOU, Wei LI, Ying YU, Yi-gang LI, Jun-li DUAN, Yue-peng WANG
Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via upregulation of p53 and suppressing FoxM1   Pages (241–251)
Ji-chao WEI, Fan-di MENG, Kai QU, Zhi-xin WANG, Qi-fei WU, Ling-qiang ZHANG, Qing PANG, Chang LIU
Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation   Pages (252–258)
Xin-li SHI, Jing YANG, Nan MAO, Jing-hua WU, Lai-feng REN, Yuan YANG, Xiao-lin YIN, Lin WEI, Ming-yuan LI, Bao-ning WANG
Modulation of the pentose phosphate pathway alters phase I metabolism of testosterone and dextromethorphan in HepG2 cells   Pages (259–267)
Wen-jing XIAO, Ting MA, Chun GE, Wen-juan XIA, Yong MAO, Run-bin SUN, Xiao-yi YU, Ji-ye AA, Guang-ji WANG
Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic uptake of hematoporphyrin monomethyl ether isomers   Pages (268–280)
Xiu-li LI, Zi-tao GUO, Ye-dong WANG, Xiao-yan CHEN, Jia LIU, Da-fang ZHONG
A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients   Pages (281–288)
Yan-xia LU, Qing-hong SU, Ke-hua Wu, Yu-peng REN, Liang LI, Tian-yan ZHOU, Wei LU